Correlation Between Takeda Pharmaceutical and Lloyds Banking

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Lloyds Banking at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Lloyds Banking into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and Lloyds Banking Group, you can compare the effects of market volatilities on Takeda Pharmaceutical and Lloyds Banking and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Lloyds Banking. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Lloyds Banking.

Diversification Opportunities for Takeda Pharmaceutical and Lloyds Banking

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Takeda and Lloyds is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and Lloyds Banking Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lloyds Banking Group and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with Lloyds Banking. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lloyds Banking Group has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Lloyds Banking go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Lloyds Banking

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to generate 0.38 times more return on investment than Lloyds Banking. However, Takeda Pharmaceutical is 2.65 times less risky than Lloyds Banking. It trades about -0.06 of its potential returns per unit of risk. Lloyds Banking Group is currently generating about -0.03 per unit of risk. If you would invest  1,320  in Takeda Pharmaceutical on August 28, 2024 and sell it today you would lose (60.00) from holding Takeda Pharmaceutical or give up 4.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.31%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  Lloyds Banking Group

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Lloyds Banking Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lloyds Banking Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Lloyds Banking is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Takeda Pharmaceutical and Lloyds Banking Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and Lloyds Banking

The main advantage of trading using opposite Takeda Pharmaceutical and Lloyds Banking positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Lloyds Banking can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lloyds Banking will offset losses from the drop in Lloyds Banking's long position.
The idea behind Takeda Pharmaceutical and Lloyds Banking Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities